Menopausal and female climacteric states
Conditions
Interventions
This is a randomized, double-blind clinical trial aimed at evaluating the effectiveness of Cimicifuga racemosa (CR) and Morus nigra L. (MN) in reducing climacteric symptoms. The study will include a t
Sponsors
Universidade Federal de Alfenas
Universidade Federal de Alfenas
Eligibility
Sex/Gender
Female
Age
45 Years to 59 Years
Inclusion criteria
Inclusion criteria: Women; aged 45 to 59 years; mentally able to provide their data; with permanent residence in the area covered by the municipality; who are seen in medical consultation during the period from March 02, 2026 to December 05, 2026; who agree to participate in the study and present inclusion characteristics in the study such as: hot flashes, vaginal dryness, anxiety, insomnia, weight gain
Exclusion criteria
Exclusion criteria: Smoking women; using conventional hormone replacement therapy; vegetarians; Asian women not registered by the team in the Medical Specialties Center Care System (CEM)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of the reduction in the intensity of climacteric symptoms using a validated clinical instrument after four months of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactTiago dos Reis
Universidade Federal de Alfenas
Outcome results
None listed